OptimizeRx Corp — Director's Dealing 2025

Aug 25, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2025-08-21

Reporting Person: Stelmakh Edward (CFO/COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-21	Common Stock	A	15625	—	Acquired	110764	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-08-21	Stock Option	$16.14	A	35156	Acquired	2030-08-21	Common Stock (35156)	Direct

Footnotes

F1: Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date.

F2: The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date.